hydantoins - CISMeF

Preferred Label : hydantoins;

MeSH definition : Compounds based on imidazolidine dione. Some derivatives are ANTICONVULSANTS.;

MeSH synonym : imidazolidine-2,4-diones; imidazolidine 2,4 diones; Hydantoin;

Wikipedia link : https://en.wikipedia.org/wiki/Hydantoin;

Is substance : O;

Details

Origin ID

D006827;

UMLS CUI

C0020209;

ATC code(s)
- hydantoin derivatives [ATC Code]
ATC code(s)
- hydantoin derivatives [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Hydantoin (substance) [SNOMED CT concept]
- Hydantoin derivative anticonvulsant (product) [Inactive SNOMED CT concept]
- Hydantoin derivatives [ICD-10 Sub-category (who)]
- Hydantoin derivatives [ICHI section]
- Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified [ICD-10 category (who)]
- Poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified, undetermined intent [ICD-10 category (who)]
- Product containing phenytoin (medicinal product) [SNOMED CT concept]
- hydantoin [Substance BNPC]
- hydantoin [SNOMED Notion]
- hydantoin derivatives [ATC Code]
Currated CISMeF NLP mapping
- Hydantoin derivatives [Bloc CIM-11]
False automatic mappings
- Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified [ICD-10 category (who)]
- Hydantoin derivatives [ICD-10 Sub-category (who)]
- Poisoning by, adverse effect of and underdosing of hydantoin derivatives [ICD-10 Sub-category]
Record concept(s)
- hydantoins [MeSH concept]
Related MeSH Supplementary Concept(s)
- (Z)-5-((4'-Fluorobiphenyl-10-yl)methylene)imidazolidine-2,4-dione [MeSH Supplementary Concept]
- 1'-(3-(3,4-dichlorophenyl)prop-2-en-1-yl)-2H,5H-spiro(imidazolidine-4,3'-indole)-2,2',5(1'H)-trione [MeSH Supplementary Concept]
- 1,3-dibromo-5,5-dimethylhydantoin [MeSH Supplementary Concept]
- 1,3-dichloro-5,5-dimethylhydantoin [MeSH Supplementary Concept]
- 1,3-dimethylol-5,5-dimethylhydantoin [MeSH Supplementary Concept]
- 1-((4-bromophenyl)sulfonyl)hydantoin [MeSH Supplementary Concept]
- 1-(2,3-dihydro-6-propoxychromen-4-ylideneamino)-3-(3-(4-methylpiperazin-1-yl)propyl)imidazolidine-2,4-dione [MeSH Supplementary Concept]
- 1-(5-(carboxyphenylthio)-2-thenylideneamino)hydantoin [MeSH Supplementary Concept]
- 1-aminohydantoin [MeSH Supplementary Concept]
- 1-methylhydantoin [MeSH Supplementary Concept]
- 1-monomethylol-5,5-dimethylhydantoin [MeSH Supplementary Concept]
- 2-(4-((2-(2-ethoxyphenoxy)ethyl)amino)butyl)tetrahydro-1H-pyrrolo(1,2-c)imidazole-1,3(2H)-dione [MeSH Supplementary Concept]
- 2-spirohydantoin-6,7-dimethoxytetrahydronaphthalene [MeSH Supplementary Concept]
- 3'-aminocyclohexanespiro-5'-hydantoin [MeSH Supplementary Concept]
- 3-((2-cyclohexyl-2-hydroxyethylidene)amino)-2,5-dioxo-4-imidazolidineheptanoic acid [MeSH Supplementary Concept]
- 3-(2,6-xylyl)-5-methylhydantoin [MeSH Supplementary Concept]
- 3-(2-(1H-imidazol-1-yl)ethyl)-5,5-dimethylhydantoin [MeSH Supplementary Concept]
- 3-(2-(1H-tetrazol-5-yl)ethyl)-5,5-dimethylimidazolidine-2,4-dione [MeSH Supplementary Concept]
- 3-(2-(3-(2-chloroethyl)-3-nitrosouriedo)ethyl)spiro(5,9'-fluorenyl)imidazolidiine-2,4-dione [MeSH Supplementary Concept]
- 3-(3-(N,N-dimethyl)aminopropyl)spiro((dihydroimidazo-2,4-dione)-5,3'-(2',3'-dihydrothieno(2,3-b)naphtho-4',9'-dione)) [MeSH Supplementary Concept]
- 3-(4-chlorobenzyl)-5-(4-nitrobenzylidene)imidazolidine-2,4-dione [MeSH Supplementary Concept]
- 3-(5-methyl-5-hydantoinyl)acetanilide [MeSH Supplementary Concept]
- 3-(5-nitrofurfurylideneamino)hydantoic acid [MeSH Supplementary Concept]
- 3-amino-5-methyl-5-phenylhydantoin [MeSH Supplementary Concept]
- 3-cyclopropyl-1-(4-(6-(1,1-dioxo-1gamma6-thiomorpholin-4-ylmethyl)-5-fluoro-pyridin-2-yl)benzyl)imidazolidine-2,4-dione [MeSH Supplementary Concept]
- 3-methyl-5-isopropylhydantoin [MeSH Supplementary Concept]
- 4-((3-(1-(4-chloro-3-(trifluoromethyl)benzoyl)piperidin-4-yl)-2,5-dioxoimidazolidin-4-yl)methyl)phenyl isoquinoline-5-sulfonate [MeSH Supplementary Concept]
- 4-((5-chloro-2-pyridinyl)oxy)-1-((((4S)-4-methyl-2,5-dioxo-4-imidazolidinyl)methyl)sulfonyl)-piperidine [MeSH Supplementary Concept]
- 4-(3,4-dimethyl-2,5-dioxo-4-(4-hydroxyphenyl)imidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile [MeSH Supplementary Concept]
- 4-(4-(hydroxymethyl)-3-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile [MeSH Supplementary Concept]
- 4-hydroxyphenylmethylene hydantoin [MeSH Supplementary Concept]
- 5'-phosphohydantocidin [MeSH Supplementary Concept]
- 5,5'-ethylenebis(5-methyl-3-(3-triethoxysilylpropyl)hydantoin) [MeSH Supplementary Concept]
- 5,5-diethylhydantoin [MeSH Supplementary Concept]
- 5,5-dimethylhydantoin [MeSH Supplementary Concept]
- 5-(2-methoxyphenyl)methylenehydantoin [MeSH Supplementary Concept]
- 5-(2-methylthioethyl)hydantoin [MeSH Supplementary Concept]
- 5-(3,4-dichlorophenyl)methylhydantoin [MeSH Supplementary Concept]
- 5-(3,5-diiodo-4-(3-isopropyl-4-hydroxyphenoxy)benzyl)imidazolidine-2,4-dione [MeSH Supplementary Concept]
- 5-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,4-imidazolidinedione [MeSH Supplementary Concept]
- 5-(3-indolylmethyl)-3-N-methylhydantoin [MeSH Supplementary Concept]
- 5-(4-fluorophenyl)-3-(2-hydroxy-3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)-5-methylhydantoin [MeSH Supplementary Concept]
- 5-(4-methoxyphenyl)-5-methyl-3-(4-((2-oxo-8-n-propyl-4-(trifluoromethyl)-2H-chromen-7-yl)oxy)butyl)imidazolidine-2,4-dione [MeSH Supplementary Concept]
- 5-(methoxymethylene)-2,4-imidazolidinedione [MeSH Supplementary Concept]
- 5-benzylhydantoin [MeSH Supplementary Concept]
- 5-carboxamido-5-formamido-2-iminohydantoin [MeSH Supplementary Concept]
- 5-ethyl-5-methylhydantoin [MeSH Supplementary Concept]
- 5-hydroxy-1-(2'-deoxyribofuranosyl)hydantoin [MeSH Supplementary Concept]
- 5-hydroxy-1-methylhydantoin [MeSH Supplementary Concept]
- 5-hydroxy-5-methylhydantoin [MeSH Supplementary Concept]
- 5-hydroxy-5-methylhydantoin 2'-deoxynucleoside [MeSH Supplementary Concept]
- 5-indolylmethylhydantoin [MeSH Supplementary Concept]
- 5-methyl-5(4-pyridyl)hydantoin [MeSH Supplementary Concept]
- 5-methyl-5-(3-phenanthryl)hydantoin [MeSH Supplementary Concept]
- 5-methyl-5-(4-pyridyl)hydantoin [MeSH Supplementary Concept]
- 5-methyl-5-phenylhydantoin [MeSH Supplementary Concept]
- 5-methyl-5-phenylhydantoin Pt(II) [MeSH Supplementary Concept]
- 5-methylhydantoin [MeSH Supplementary Concept]
- 5-phenylhydantoin [MeSH Supplementary Concept]
- 5-phenylmethylenehydantoin [MeSH Supplementary Concept]
- 7'-hydroxy-2',3'-dihydro-1'H,2H,5H-spiro(imidazolidine-4,4'-quinoline)-2,5-dione [MeSH Supplementary Concept]
- 7,8-benzo-1,3-diazaspiro-(4,5)-decane-2,4-dione [MeSH Supplementary Concept]
- AL 3152 [MeSH Supplementary Concept]
- AL 4114 [MeSH Supplementary Concept]
- AUT1 compound [MeSH Supplementary Concept]
- AUT2 compound [MeSH Supplementary Concept]
- AZD6605 [MeSH Supplementary Concept]
- BW 245C [MeSH Supplementary Concept]
- BW A868C [MeSH Supplementary Concept]
- C-2-thioxo-hydantocidin [MeSH Supplementary Concept]
- DOTA-1-(4-aminobutyl)-5-(4-bromobenzyl)-3-(3,5-dichlorophenyl)-5-methylimidazolidine-2,4-dione [MeSH Supplementary Concept]
- EX15 hydantoin compound [MeSH Supplementary Concept]
- FCE 22716 [MeSH Supplementary Concept]
- FCE 24220 [MeSH Supplementary Concept]
- M 16209 [MeSH Supplementary Concept]
- M 16287 [MeSH Supplementary Concept]
- N-((4-(1-methylimidazol-2-yl)-2,5-dioxoimidazolidin-4-yl)methyl)-5-(trifluoromethyl)benzofuran-2-carboxamide [MeSH Supplementary Concept]
- N-(4-chloro-3-nitrophenylsulfonyl)-2-(4-((3'-methylbiphenyl-4-yl)methyl)-2,5-dioxoimidazolidin-1-yl)-3-phenylpropanamide [MeSH Supplementary Concept]
- N-acetyl-5'-phosphohydantocidin [MeSH Supplementary Concept]
- RE1 hydantoin compound [MeSH Supplementary Concept]
- RU 58642 [MeSH Supplementary Concept]
- Ro 13-3978 [MeSH Supplementary Concept]
- S 3429 [MeSH Supplementary Concept]
- SCH 900567 [MeSH Supplementary Concept]
- UPR1024 [MeSH Supplementary Concept]
- alconil [MeSH Supplementary Concept]
- azimilide [MeSH Supplementary Concept]
- bis(5-ethyl-5-phenylhydantoin)bispyridine Cu(II) [MeSH Supplementary Concept]
- camphor-2-spirohydantoin [MeSH Supplementary Concept]
- chlordantoin [MeSH Supplementary Concept]
- cypenhymustine [MeSH Supplementary Concept]
- dehydroguanidinohydantoin [MeSH Supplementary Concept]
- di-halo [MeSH Supplementary Concept]
- dimethoxyhydantoin [MeSH Supplementary Concept]
- dimethylhydantoin-formaldehyde resin [MeSH Supplementary Concept]
- ethotoin [MeSH Supplementary Concept]
- glucopyranose spirohydantoin [MeSH Supplementary Concept]
- glucopyranosylidene-spiro-hydantoin [MeSH Supplementary Concept]
- granatane-3-spiro-5'-hydantoin [MeSH Supplementary Concept]
- guanidinohydantoin [MeSH Supplementary Concept]
- guanidinohydantoin-2'-deoxynucleoside-5'-triphosphate [MeSH Supplementary Concept]
- histidine hydantoin [MeSH Supplementary Concept]
- hydantocidin [MeSH Supplementary Concept]
- hydantoin 3-phenyl-5-(4-ethylphenyl)-imidazolidine-2,4-dione [MeSH Supplementary Concept]
- hydantoin 454C77 [MeSH Supplementary Concept]
- hydantoin-5-propionic acid [MeSH Supplementary Concept]
- imirestat [MeSH Supplementary Concept]
- iprodione [MeSH Supplementary Concept]
- naloxone-6-spirohydantoin [MeSH Supplementary Concept]
- nifurmazole [MeSH Supplementary Concept]
- oxymorphone-6-spirohydantoin [MeSH Supplementary Concept]
- parabanic acid [MeSH Supplementary Concept]
- propyl-2-(8-(3,4-difluorobenzyl)-2',5'-dioxo-8-azaspiro(bicyclo(3.2.1)octane-3,4'-imidazolidine)-1'-yl)acetate [MeSH Supplementary Concept]
- spirodihydantoin [MeSH Supplementary Concept]
- spiroiminodihydantoin nucleoside [MeSH Supplementary Concept]
- spiroiminodihydantoin-2'-deoxynucleoside-5'-triphosphate [MeSH Supplementary Concept]
- spiromustine [MeSH Supplementary Concept]
- sulfochloranthine [MeSH Supplementary Concept]
- valine methylhydantoin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Hydantoin derivatives [Bloc CIM-11]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients